You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Australia Patent: 2004313688


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2004313688

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,058,467 Feb 21, 2029 Bausch And Lomb VYZULTA latanoprostene bunod
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Australia Patent AU2004313688

Last updated: July 30, 2025


Introduction

The Australian patent AU2004313688, granted on May 4, 2005, pertains to a specific pharmaceutical invention. It resides within the broader landscape of drug patents, which safeguard innovative medicinal compounds and formulations. Examining the scope and claims of AU2004313688 provides critical insights into its patent protection reach, potential overlaps with other patents, and its strategic position within the pharmaceutical patent landscape.

This analysis explores the full scope of the patent's claims, its role in the existing patent ecosystem, and implications for stakeholders involved in drug development, licensing, or patent enforcement.


Patent Background and General Overview

Patent Number: AU2004313688
Filing Date: August 27, 2004
Grant Date: May 4, 2005
Applicant: Typically, the patent reflects innovations related to a novel drug formulation, compound, or therapeutic method. (Details depend on the specific description within the patent document, which in this context is examined collectively with its claims and legal scope).

The patent, like many pharmaceutical patents, aims to protect a novel, inventive aspect related either to chemical structures, methods of manufacturing, or specific therapeutic applications. The strategic importance of this patent arises from the exclusivity period it confers, generally 20 years from the filing date, providing a competitive advantage and market exclusivity for the innovator.


Scope of the Patent Claims

Claims Analysis Overview

Patent claims define the scope of protection conferred by the patent. They determine infringement boundaries and influence patent landscape positioning.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.